Global Newborn Screening for SMA and SCID Market Research Report 2024(Status and Outlook)
Report Overview:
The Global Newborn Screening for SMA and SCID Market Size was estimated at USD 67.35 million in 2023 and is projected to reach USD 129.48 million by 2029, exhibiting a CAGR of 11.51% during the forecast period.
This report provides a deep insight into the global Newborn Screening for SMA and SCID market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Newborn Screening for SMA and SCID Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Newborn Screening for SMA and SCID market in any manner.
Global Newborn Screening for SMA and SCID Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Perkinelmer
Thermo Fisher
ImmunoIVD
Labsystems Diagnostics
Market Segmentation (by Type)
Instruments
Kits
Software
Market Segmentation (by Application)
SCID Screening
SMA Screening
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Newborn Screening for SMA and SCID Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
The Global Newborn Screening for SMA and SCID Market Size was estimated at USD 67.35 million in 2023 and is projected to reach USD 129.48 million by 2029, exhibiting a CAGR of 11.51% during the forecast period.
This report provides a deep insight into the global Newborn Screening for SMA and SCID market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Newborn Screening for SMA and SCID Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Newborn Screening for SMA and SCID market in any manner.
Global Newborn Screening for SMA and SCID Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Perkinelmer
Thermo Fisher
ImmunoIVD
Labsystems Diagnostics
Market Segmentation (by Type)
Instruments
Kits
Software
Market Segmentation (by Application)
SCID Screening
SMA Screening
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Newborn Screening for SMA and SCID Market
- Overview of the regional outlook of the Newborn Screening for SMA and SCID Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Newborn Screening for SMA and SCID Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Newborn Screening for SMA and SCID
1.2 Key Market Segments
1.2.1 Newborn Screening for SMA and SCID Segment by Type
1.2.2 Newborn Screening for SMA and SCID Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NEWBORN SCREENING FOR SMA AND SCID MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Newborn Screening for SMA and SCID Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Newborn Screening for SMA and SCID Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NEWBORN SCREENING FOR SMA AND SCID MARKET COMPETITIVE LANDSCAPE
3.1 Global Newborn Screening for SMA and SCID Sales by Manufacturers (2019-2024)
3.2 Global Newborn Screening for SMA and SCID Revenue Market Share by Manufacturers (2019-2024)
3.3 Newborn Screening for SMA and SCID Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Newborn Screening for SMA and SCID Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Newborn Screening for SMA and SCID Sales Sites, Area Served, Product Type
3.6 Newborn Screening for SMA and SCID Market Competitive Situation and Trends
3.6.1 Newborn Screening for SMA and SCID Market Concentration Rate
3.6.2 Global 5 and 10 Largest Newborn Screening for SMA and SCID Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NEWBORN SCREENING FOR SMA AND SCID INDUSTRY CHAIN ANALYSIS
4.1 Newborn Screening for SMA and SCID Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NEWBORN SCREENING FOR SMA AND SCID MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NEWBORN SCREENING FOR SMA AND SCID MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Newborn Screening for SMA and SCID Sales Market Share by Type (2019-2024)
6.3 Global Newborn Screening for SMA and SCID Market Size Market Share by Type (2019-2024)
6.4 Global Newborn Screening for SMA and SCID Price by Type (2019-2024)
7 NEWBORN SCREENING FOR SMA AND SCID MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Newborn Screening for SMA and SCID Market Sales by Application (2019-2024)
7.3 Global Newborn Screening for SMA and SCID Market Size (M USD) by Application (2019-2024)
7.4 Global Newborn Screening for SMA and SCID Sales Growth Rate by Application (2019-2024)
8 NEWBORN SCREENING FOR SMA AND SCID MARKET SEGMENTATION BY REGION
8.1 Global Newborn Screening for SMA and SCID Sales by Region
8.1.1 Global Newborn Screening for SMA and SCID Sales by Region
8.1.2 Global Newborn Screening for SMA and SCID Sales Market Share by Region
8.2 North America
8.2.1 North America Newborn Screening for SMA and SCID Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Newborn Screening for SMA and SCID Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Newborn Screening for SMA and SCID Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Newborn Screening for SMA and SCID Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Newborn Screening for SMA and SCID Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Perkinelmer
9.1.1 Perkinelmer Newborn Screening for SMA and SCID Basic Information
9.1.2 Perkinelmer Newborn Screening for SMA and SCID Product Overview
9.1.3 Perkinelmer Newborn Screening for SMA and SCID Product Market Performance
9.1.4 Perkinelmer Business Overview
9.1.5 Perkinelmer Newborn Screening for SMA and SCID SWOT Analysis
9.1.6 Perkinelmer Recent Developments
9.2 Thermo Fisher
9.2.1 Thermo Fisher Newborn Screening for SMA and SCID Basic Information
9.2.2 Thermo Fisher Newborn Screening for SMA and SCID Product Overview
9.2.3 Thermo Fisher Newborn Screening for SMA and SCID Product Market Performance
9.2.4 Thermo Fisher Business Overview
9.2.5 Thermo Fisher Newborn Screening for SMA and SCID SWOT Analysis
9.2.6 Thermo Fisher Recent Developments
9.3 ImmunoIVD
9.3.1 ImmunoIVD Newborn Screening for SMA and SCID Basic Information
9.3.2 ImmunoIVD Newborn Screening for SMA and SCID Product Overview
9.3.3 ImmunoIVD Newborn Screening for SMA and SCID Product Market Performance
9.3.4 ImmunoIVD Newborn Screening for SMA and SCID SWOT Analysis
9.3.5 ImmunoIVD Business Overview
9.3.6 ImmunoIVD Recent Developments
9.4 Labsystems Diagnostics
9.4.1 Labsystems Diagnostics Newborn Screening for SMA and SCID Basic Information
9.4.2 Labsystems Diagnostics Newborn Screening for SMA and SCID Product Overview
9.4.3 Labsystems Diagnostics Newborn Screening for SMA and SCID Product Market Performance
9.4.4 Labsystems Diagnostics Business Overview
9.4.5 Labsystems Diagnostics Recent Developments
10 NEWBORN SCREENING FOR SMA AND SCID MARKET FORECAST BY REGION
10.1 Global Newborn Screening for SMA and SCID Market Size Forecast
10.2 Global Newborn Screening for SMA and SCID Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Newborn Screening for SMA and SCID Market Size Forecast by Country
10.2.3 Asia Pacific Newborn Screening for SMA and SCID Market Size Forecast by Region
10.2.4 South America Newborn Screening for SMA and SCID Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Newborn Screening for SMA and SCID by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Newborn Screening for SMA and SCID Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Newborn Screening for SMA and SCID by Type (2025-2030)
11.1.2 Global Newborn Screening for SMA and SCID Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Newborn Screening for SMA and SCID by Type (2025-2030)
11.2 Global Newborn Screening for SMA and SCID Market Forecast by Application (2025-2030)
11.2.1 Global Newborn Screening for SMA and SCID Sales (Kilotons) Forecast by Application
11.2.2 Global Newborn Screening for SMA and SCID Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Newborn Screening for SMA and SCID
1.2 Key Market Segments
1.2.1 Newborn Screening for SMA and SCID Segment by Type
1.2.2 Newborn Screening for SMA and SCID Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NEWBORN SCREENING FOR SMA AND SCID MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Newborn Screening for SMA and SCID Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Newborn Screening for SMA and SCID Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NEWBORN SCREENING FOR SMA AND SCID MARKET COMPETITIVE LANDSCAPE
3.1 Global Newborn Screening for SMA and SCID Sales by Manufacturers (2019-2024)
3.2 Global Newborn Screening for SMA and SCID Revenue Market Share by Manufacturers (2019-2024)
3.3 Newborn Screening for SMA and SCID Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Newborn Screening for SMA and SCID Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Newborn Screening for SMA and SCID Sales Sites, Area Served, Product Type
3.6 Newborn Screening for SMA and SCID Market Competitive Situation and Trends
3.6.1 Newborn Screening for SMA and SCID Market Concentration Rate
3.6.2 Global 5 and 10 Largest Newborn Screening for SMA and SCID Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NEWBORN SCREENING FOR SMA AND SCID INDUSTRY CHAIN ANALYSIS
4.1 Newborn Screening for SMA and SCID Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NEWBORN SCREENING FOR SMA AND SCID MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NEWBORN SCREENING FOR SMA AND SCID MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Newborn Screening for SMA and SCID Sales Market Share by Type (2019-2024)
6.3 Global Newborn Screening for SMA and SCID Market Size Market Share by Type (2019-2024)
6.4 Global Newborn Screening for SMA and SCID Price by Type (2019-2024)
7 NEWBORN SCREENING FOR SMA AND SCID MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Newborn Screening for SMA and SCID Market Sales by Application (2019-2024)
7.3 Global Newborn Screening for SMA and SCID Market Size (M USD) by Application (2019-2024)
7.4 Global Newborn Screening for SMA and SCID Sales Growth Rate by Application (2019-2024)
8 NEWBORN SCREENING FOR SMA AND SCID MARKET SEGMENTATION BY REGION
8.1 Global Newborn Screening for SMA and SCID Sales by Region
8.1.1 Global Newborn Screening for SMA and SCID Sales by Region
8.1.2 Global Newborn Screening for SMA and SCID Sales Market Share by Region
8.2 North America
8.2.1 North America Newborn Screening for SMA and SCID Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Newborn Screening for SMA and SCID Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Newborn Screening for SMA and SCID Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Newborn Screening for SMA and SCID Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Newborn Screening for SMA and SCID Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Perkinelmer
9.1.1 Perkinelmer Newborn Screening for SMA and SCID Basic Information
9.1.2 Perkinelmer Newborn Screening for SMA and SCID Product Overview
9.1.3 Perkinelmer Newborn Screening for SMA and SCID Product Market Performance
9.1.4 Perkinelmer Business Overview
9.1.5 Perkinelmer Newborn Screening for SMA and SCID SWOT Analysis
9.1.6 Perkinelmer Recent Developments
9.2 Thermo Fisher
9.2.1 Thermo Fisher Newborn Screening for SMA and SCID Basic Information
9.2.2 Thermo Fisher Newborn Screening for SMA and SCID Product Overview
9.2.3 Thermo Fisher Newborn Screening for SMA and SCID Product Market Performance
9.2.4 Thermo Fisher Business Overview
9.2.5 Thermo Fisher Newborn Screening for SMA and SCID SWOT Analysis
9.2.6 Thermo Fisher Recent Developments
9.3 ImmunoIVD
9.3.1 ImmunoIVD Newborn Screening for SMA and SCID Basic Information
9.3.2 ImmunoIVD Newborn Screening for SMA and SCID Product Overview
9.3.3 ImmunoIVD Newborn Screening for SMA and SCID Product Market Performance
9.3.4 ImmunoIVD Newborn Screening for SMA and SCID SWOT Analysis
9.3.5 ImmunoIVD Business Overview
9.3.6 ImmunoIVD Recent Developments
9.4 Labsystems Diagnostics
9.4.1 Labsystems Diagnostics Newborn Screening for SMA and SCID Basic Information
9.4.2 Labsystems Diagnostics Newborn Screening for SMA and SCID Product Overview
9.4.3 Labsystems Diagnostics Newborn Screening for SMA and SCID Product Market Performance
9.4.4 Labsystems Diagnostics Business Overview
9.4.5 Labsystems Diagnostics Recent Developments
10 NEWBORN SCREENING FOR SMA AND SCID MARKET FORECAST BY REGION
10.1 Global Newborn Screening for SMA and SCID Market Size Forecast
10.2 Global Newborn Screening for SMA and SCID Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Newborn Screening for SMA and SCID Market Size Forecast by Country
10.2.3 Asia Pacific Newborn Screening for SMA and SCID Market Size Forecast by Region
10.2.4 South America Newborn Screening for SMA and SCID Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Newborn Screening for SMA and SCID by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Newborn Screening for SMA and SCID Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Newborn Screening for SMA and SCID by Type (2025-2030)
11.1.2 Global Newborn Screening for SMA and SCID Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Newborn Screening for SMA and SCID by Type (2025-2030)
11.2 Global Newborn Screening for SMA and SCID Market Forecast by Application (2025-2030)
11.2.1 Global Newborn Screening for SMA and SCID Sales (Kilotons) Forecast by Application
11.2.2 Global Newborn Screening for SMA and SCID Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Newborn Screening for SMA and SCID Market Size Comparison by Region (M USD)
Table 5. Global Newborn Screening for SMA and SCID Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Newborn Screening for SMA and SCID Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Newborn Screening for SMA and SCID Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Newborn Screening for SMA and SCID Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Newborn Screening for SMA and SCID as of 2022)
Table 10. Global Market Newborn Screening for SMA and SCID Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Newborn Screening for SMA and SCID Sales Sites and Area Served
Table 12. Manufacturers Newborn Screening for SMA and SCID Product Type
Table 13. Global Newborn Screening for SMA and SCID Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Newborn Screening for SMA and SCID
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Newborn Screening for SMA and SCID Market Challenges
Table 22. Global Newborn Screening for SMA and SCID Sales by Type (Kilotons)
Table 23. Global Newborn Screening for SMA and SCID Market Size by Type (M USD)
Table 24. Global Newborn Screening for SMA and SCID Sales (Kilotons) by Type (2019-2024)
Table 25. Global Newborn Screening for SMA and SCID Sales Market Share by Type (2019-2024)
Table 26. Global Newborn Screening for SMA and SCID Market Size (M USD) by Type (2019-2024)
Table 27. Global Newborn Screening for SMA and SCID Market Size Share by Type (2019-2024)
Table 28. Global Newborn Screening for SMA and SCID Price (USD/Ton) by Type (2019-2024)
Table 29. Global Newborn Screening for SMA and SCID Sales (Kilotons) by Application
Table 30. Global Newborn Screening for SMA and SCID Market Size by Application
Table 31. Global Newborn Screening for SMA and SCID Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Newborn Screening for SMA and SCID Sales Market Share by Application (2019-2024)
Table 33. Global Newborn Screening for SMA and SCID Sales by Application (2019-2024) & (M USD)
Table 34. Global Newborn Screening for SMA and SCID Market Share by Application (2019-2024)
Table 35. Global Newborn Screening for SMA and SCID Sales Growth Rate by Application (2019-2024)
Table 36. Global Newborn Screening for SMA and SCID Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Newborn Screening for SMA and SCID Sales Market Share by Region (2019-2024)
Table 38. North America Newborn Screening for SMA and SCID Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Newborn Screening for SMA and SCID Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Newborn Screening for SMA and SCID Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Newborn Screening for SMA and SCID Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Newborn Screening for SMA and SCID Sales by Region (2019-2024) & (Kilotons)
Table 43. Perkinelmer Newborn Screening for SMA and SCID Basic Information
Table 44. Perkinelmer Newborn Screening for SMA and SCID Product Overview
Table 45. Perkinelmer Newborn Screening for SMA and SCID Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Perkinelmer Business Overview
Table 47. Perkinelmer Newborn Screening for SMA and SCID SWOT Analysis
Table 48. Perkinelmer Recent Developments
Table 49. Thermo Fisher Newborn Screening for SMA and SCID Basic Information
Table 50. Thermo Fisher Newborn Screening for SMA and SCID Product Overview
Table 51. Thermo Fisher Newborn Screening for SMA and SCID Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Thermo Fisher Business Overview
Table 53. Thermo Fisher Newborn Screening for SMA and SCID SWOT Analysis
Table 54. Thermo Fisher Recent Developments
Table 55. ImmunoIVD Newborn Screening for SMA and SCID Basic Information
Table 56. ImmunoIVD Newborn Screening for SMA and SCID Product Overview
Table 57. ImmunoIVD Newborn Screening for SMA and SCID Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. ImmunoIVD Newborn Screening for SMA and SCID SWOT Analysis
Table 59. ImmunoIVD Business Overview
Table 60. ImmunoIVD Recent Developments
Table 61. Labsystems Diagnostics Newborn Screening for SMA and SCID Basic Information
Table 62. Labsystems Diagnostics Newborn Screening for SMA and SCID Product Overview
Table 63. Labsystems Diagnostics Newborn Screening for SMA and SCID Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Labsystems Diagnostics Business Overview
Table 65. Labsystems Diagnostics Recent Developments
Table 66. Global Newborn Screening for SMA and SCID Sales Forecast by Region (2025-2030) & (Kilotons)
Table 67. Global Newborn Screening for SMA and SCID Market Size Forecast by Region (2025-2030) & (M USD)
Table 68. North America Newborn Screening for SMA and SCID Sales Forecast by Country (2025-2030) & (Kilotons)
Table 69. North America Newborn Screening for SMA and SCID Market Size Forecast by Country (2025-2030) & (M USD)
Table 70. Europe Newborn Screening for SMA and SCID Sales Forecast by Country (2025-2030) & (Kilotons)
Table 71. Europe Newborn Screening for SMA and SCID Market Size Forecast by Country (2025-2030) & (M USD)
Table 72. Asia Pacific Newborn Screening for SMA and SCID Sales Forecast by Region (2025-2030) & (Kilotons)
Table 73. Asia Pacific Newborn Screening for SMA and SCID Market Size Forecast by Region (2025-2030) & (M USD)
Table 74. South America Newborn Screening for SMA and SCID Sales Forecast by Country (2025-2030) & (Kilotons)
Table 75. South America Newborn Screening for SMA and SCID Market Size Forecast by Country (2025-2030) & (M USD)
Table 76. Middle East and Africa Newborn Screening for SMA and SCID Consumption Forecast by Country (2025-2030) & (Units)
Table 77. Middle East and Africa Newborn Screening for SMA and SCID Market Size Forecast by Country (2025-2030) & (M USD)
Table 78. Global Newborn Screening for SMA and SCID Sales Forecast by Type (2025-2030) & (Kilotons)
Table 79. Global Newborn Screening for SMA and SCID Market Size Forecast by Type (2025-2030) & (M USD)
Table 80. Global Newborn Screening for SMA and SCID Price Forecast by Type (2025-2030) & (USD/Ton)
Table 81. Global Newborn Screening for SMA and SCID Sales (Kilotons) Forecast by Application (2025-2030)
Table 82. Global Newborn Screening for SMA and SCID Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Newborn Screening for SMA and SCID Market Size Comparison by Region (M USD)
Table 5. Global Newborn Screening for SMA and SCID Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Newborn Screening for SMA and SCID Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Newborn Screening for SMA and SCID Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Newborn Screening for SMA and SCID Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Newborn Screening for SMA and SCID as of 2022)
Table 10. Global Market Newborn Screening for SMA and SCID Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Newborn Screening for SMA and SCID Sales Sites and Area Served
Table 12. Manufacturers Newborn Screening for SMA and SCID Product Type
Table 13. Global Newborn Screening for SMA and SCID Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Newborn Screening for SMA and SCID
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Newborn Screening for SMA and SCID Market Challenges
Table 22. Global Newborn Screening for SMA and SCID Sales by Type (Kilotons)
Table 23. Global Newborn Screening for SMA and SCID Market Size by Type (M USD)
Table 24. Global Newborn Screening for SMA and SCID Sales (Kilotons) by Type (2019-2024)
Table 25. Global Newborn Screening for SMA and SCID Sales Market Share by Type (2019-2024)
Table 26. Global Newborn Screening for SMA and SCID Market Size (M USD) by Type (2019-2024)
Table 27. Global Newborn Screening for SMA and SCID Market Size Share by Type (2019-2024)
Table 28. Global Newborn Screening for SMA and SCID Price (USD/Ton) by Type (2019-2024)
Table 29. Global Newborn Screening for SMA and SCID Sales (Kilotons) by Application
Table 30. Global Newborn Screening for SMA and SCID Market Size by Application
Table 31. Global Newborn Screening for SMA and SCID Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Newborn Screening for SMA and SCID Sales Market Share by Application (2019-2024)
Table 33. Global Newborn Screening for SMA and SCID Sales by Application (2019-2024) & (M USD)
Table 34. Global Newborn Screening for SMA and SCID Market Share by Application (2019-2024)
Table 35. Global Newborn Screening for SMA and SCID Sales Growth Rate by Application (2019-2024)
Table 36. Global Newborn Screening for SMA and SCID Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Newborn Screening for SMA and SCID Sales Market Share by Region (2019-2024)
Table 38. North America Newborn Screening for SMA and SCID Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Newborn Screening for SMA and SCID Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Newborn Screening for SMA and SCID Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Newborn Screening for SMA and SCID Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Newborn Screening for SMA and SCID Sales by Region (2019-2024) & (Kilotons)
Table 43. Perkinelmer Newborn Screening for SMA and SCID Basic Information
Table 44. Perkinelmer Newborn Screening for SMA and SCID Product Overview
Table 45. Perkinelmer Newborn Screening for SMA and SCID Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Perkinelmer Business Overview
Table 47. Perkinelmer Newborn Screening for SMA and SCID SWOT Analysis
Table 48. Perkinelmer Recent Developments
Table 49. Thermo Fisher Newborn Screening for SMA and SCID Basic Information
Table 50. Thermo Fisher Newborn Screening for SMA and SCID Product Overview
Table 51. Thermo Fisher Newborn Screening for SMA and SCID Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Thermo Fisher Business Overview
Table 53. Thermo Fisher Newborn Screening for SMA and SCID SWOT Analysis
Table 54. Thermo Fisher Recent Developments
Table 55. ImmunoIVD Newborn Screening for SMA and SCID Basic Information
Table 56. ImmunoIVD Newborn Screening for SMA and SCID Product Overview
Table 57. ImmunoIVD Newborn Screening for SMA and SCID Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. ImmunoIVD Newborn Screening for SMA and SCID SWOT Analysis
Table 59. ImmunoIVD Business Overview
Table 60. ImmunoIVD Recent Developments
Table 61. Labsystems Diagnostics Newborn Screening for SMA and SCID Basic Information
Table 62. Labsystems Diagnostics Newborn Screening for SMA and SCID Product Overview
Table 63. Labsystems Diagnostics Newborn Screening for SMA and SCID Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Labsystems Diagnostics Business Overview
Table 65. Labsystems Diagnostics Recent Developments
Table 66. Global Newborn Screening for SMA and SCID Sales Forecast by Region (2025-2030) & (Kilotons)
Table 67. Global Newborn Screening for SMA and SCID Market Size Forecast by Region (2025-2030) & (M USD)
Table 68. North America Newborn Screening for SMA and SCID Sales Forecast by Country (2025-2030) & (Kilotons)
Table 69. North America Newborn Screening for SMA and SCID Market Size Forecast by Country (2025-2030) & (M USD)
Table 70. Europe Newborn Screening for SMA and SCID Sales Forecast by Country (2025-2030) & (Kilotons)
Table 71. Europe Newborn Screening for SMA and SCID Market Size Forecast by Country (2025-2030) & (M USD)
Table 72. Asia Pacific Newborn Screening for SMA and SCID Sales Forecast by Region (2025-2030) & (Kilotons)
Table 73. Asia Pacific Newborn Screening for SMA and SCID Market Size Forecast by Region (2025-2030) & (M USD)
Table 74. South America Newborn Screening for SMA and SCID Sales Forecast by Country (2025-2030) & (Kilotons)
Table 75. South America Newborn Screening for SMA and SCID Market Size Forecast by Country (2025-2030) & (M USD)
Table 76. Middle East and Africa Newborn Screening for SMA and SCID Consumption Forecast by Country (2025-2030) & (Units)
Table 77. Middle East and Africa Newborn Screening for SMA and SCID Market Size Forecast by Country (2025-2030) & (M USD)
Table 78. Global Newborn Screening for SMA and SCID Sales Forecast by Type (2025-2030) & (Kilotons)
Table 79. Global Newborn Screening for SMA and SCID Market Size Forecast by Type (2025-2030) & (M USD)
Table 80. Global Newborn Screening for SMA and SCID Price Forecast by Type (2025-2030) & (USD/Ton)
Table 81. Global Newborn Screening for SMA and SCID Sales (Kilotons) Forecast by Application (2025-2030)
Table 82. Global Newborn Screening for SMA and SCID Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Newborn Screening for SMA and SCID
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Newborn Screening for SMA and SCID Market Size (M USD), 2019-2030
Figure 5. Global Newborn Screening for SMA and SCID Market Size (M USD) (2019-2030)
Figure 6. Global Newborn Screening for SMA and SCID Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Newborn Screening for SMA and SCID Market Size by Country (M USD)
Figure 11. Newborn Screening for SMA and SCID Sales Share by Manufacturers in 2023
Figure 12. Global Newborn Screening for SMA and SCID Revenue Share by Manufacturers in 2023
Figure 13. Newborn Screening for SMA and SCID Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Newborn Screening for SMA and SCID Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Newborn Screening for SMA and SCID Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Newborn Screening for SMA and SCID Market Share by Type
Figure 18. Sales Market Share of Newborn Screening for SMA and SCID by Type (2019-2024)
Figure 19. Sales Market Share of Newborn Screening for SMA and SCID by Type in 2023
Figure 20. Market Size Share of Newborn Screening for SMA and SCID by Type (2019-2024)
Figure 21. Market Size Market Share of Newborn Screening for SMA and SCID by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Newborn Screening for SMA and SCID Market Share by Application
Figure 24. Global Newborn Screening for SMA and SCID Sales Market Share by Application (2019-2024)
Figure 25. Global Newborn Screening for SMA and SCID Sales Market Share by Application in 2023
Figure 26. Global Newborn Screening for SMA and SCID Market Share by Application (2019-2024)
Figure 27. Global Newborn Screening for SMA and SCID Market Share by Application in 2023
Figure 28. Global Newborn Screening for SMA and SCID Sales Growth Rate by Application (2019-2024)
Figure 29. Global Newborn Screening for SMA and SCID Sales Market Share by Region (2019-2024)
Figure 30. North America Newborn Screening for SMA and SCID Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Newborn Screening for SMA and SCID Sales Market Share by Country in 2023
Figure 32. U.S. Newborn Screening for SMA and SCID Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Newborn Screening for SMA and SCID Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Newborn Screening for SMA and SCID Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Newborn Screening for SMA and SCID Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Newborn Screening for SMA and SCID Sales Market Share by Country in 2023
Figure 37. Germany Newborn Screening for SMA and SCID Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Newborn Screening for SMA and SCID Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Newborn Screening for SMA and SCID Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Newborn Screening for SMA and SCID Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Newborn Screening for SMA and SCID Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Newborn Screening for SMA and SCID Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Newborn Screening for SMA and SCID Sales Market Share by Region in 2023
Figure 44. China Newborn Screening for SMA and SCID Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Newborn Screening for SMA and SCID Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Newborn Screening for SMA and SCID Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Newborn Screening for SMA and SCID Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Newborn Screening for SMA and SCID Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Newborn Screening for SMA and SCID Sales and Growth Rate (Kilotons)
Figure 50. South America Newborn Screening for SMA and SCID Sales Market Share by Country in 2023
Figure 51. Brazil Newborn Screening for SMA and SCID Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Newborn Screening for SMA and SCID Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Newborn Screening for SMA and SCID Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Newborn Screening for SMA and SCID Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Newborn Screening for SMA and SCID Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Newborn Screening for SMA and SCID Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Newborn Screening for SMA and SCID Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Newborn Screening for SMA and SCID Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Newborn Screening for SMA and SCID Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Newborn Screening for SMA and SCID Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Newborn Screening for SMA and SCID Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Newborn Screening for SMA and SCID Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Newborn Screening for SMA and SCID Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Newborn Screening for SMA and SCID Market Share Forecast by Type (2025-2030)
Figure 65. Global Newborn Screening for SMA and SCID Sales Forecast by Application (2025-2030)
Figure 66. Global Newborn Screening for SMA and SCID Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Newborn Screening for SMA and SCID
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Newborn Screening for SMA and SCID Market Size (M USD), 2019-2030
Figure 5. Global Newborn Screening for SMA and SCID Market Size (M USD) (2019-2030)
Figure 6. Global Newborn Screening for SMA and SCID Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Newborn Screening for SMA and SCID Market Size by Country (M USD)
Figure 11. Newborn Screening for SMA and SCID Sales Share by Manufacturers in 2023
Figure 12. Global Newborn Screening for SMA and SCID Revenue Share by Manufacturers in 2023
Figure 13. Newborn Screening for SMA and SCID Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Newborn Screening for SMA and SCID Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Newborn Screening for SMA and SCID Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Newborn Screening for SMA and SCID Market Share by Type
Figure 18. Sales Market Share of Newborn Screening for SMA and SCID by Type (2019-2024)
Figure 19. Sales Market Share of Newborn Screening for SMA and SCID by Type in 2023
Figure 20. Market Size Share of Newborn Screening for SMA and SCID by Type (2019-2024)
Figure 21. Market Size Market Share of Newborn Screening for SMA and SCID by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Newborn Screening for SMA and SCID Market Share by Application
Figure 24. Global Newborn Screening for SMA and SCID Sales Market Share by Application (2019-2024)
Figure 25. Global Newborn Screening for SMA and SCID Sales Market Share by Application in 2023
Figure 26. Global Newborn Screening for SMA and SCID Market Share by Application (2019-2024)
Figure 27. Global Newborn Screening for SMA and SCID Market Share by Application in 2023
Figure 28. Global Newborn Screening for SMA and SCID Sales Growth Rate by Application (2019-2024)
Figure 29. Global Newborn Screening for SMA and SCID Sales Market Share by Region (2019-2024)
Figure 30. North America Newborn Screening for SMA and SCID Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Newborn Screening for SMA and SCID Sales Market Share by Country in 2023
Figure 32. U.S. Newborn Screening for SMA and SCID Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Newborn Screening for SMA and SCID Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Newborn Screening for SMA and SCID Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Newborn Screening for SMA and SCID Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Newborn Screening for SMA and SCID Sales Market Share by Country in 2023
Figure 37. Germany Newborn Screening for SMA and SCID Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Newborn Screening for SMA and SCID Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Newborn Screening for SMA and SCID Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Newborn Screening for SMA and SCID Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Newborn Screening for SMA and SCID Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Newborn Screening for SMA and SCID Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Newborn Screening for SMA and SCID Sales Market Share by Region in 2023
Figure 44. China Newborn Screening for SMA and SCID Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Newborn Screening for SMA and SCID Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Newborn Screening for SMA and SCID Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Newborn Screening for SMA and SCID Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Newborn Screening for SMA and SCID Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Newborn Screening for SMA and SCID Sales and Growth Rate (Kilotons)
Figure 50. South America Newborn Screening for SMA and SCID Sales Market Share by Country in 2023
Figure 51. Brazil Newborn Screening for SMA and SCID Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Newborn Screening for SMA and SCID Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Newborn Screening for SMA and SCID Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Newborn Screening for SMA and SCID Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Newborn Screening for SMA and SCID Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Newborn Screening for SMA and SCID Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Newborn Screening for SMA and SCID Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Newborn Screening for SMA and SCID Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Newborn Screening for SMA and SCID Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Newborn Screening for SMA and SCID Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Newborn Screening for SMA and SCID Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Newborn Screening for SMA and SCID Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Newborn Screening for SMA and SCID Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Newborn Screening for SMA and SCID Market Share Forecast by Type (2025-2030)
Figure 65. Global Newborn Screening for SMA and SCID Sales Forecast by Application (2025-2030)
Figure 66. Global Newborn Screening for SMA and SCID Market Share Forecast by Application (2025-2030)
